$XXII
22nd Century Group, Inc.

2013 Q4 Form 10-Q Financial Statement

#000114420413060642 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $7.230M $52.50K $0.00
YoY Change 234.76% -100.0%
Cost Of Revenue $440.0K $20.55K $10.00K
YoY Change 4300.0% -66.23% -94.74%
Gross Profit $6.780M $31.95K $0.00
YoY Change -170.73% -100.0%
Gross Profit Margin 93.78% 60.86%
Selling, General & Admin $650.0K $912.3K $490.0K
YoY Change 32.65% 139.08% 16.67%
% of Gross Profit 9.59% 2855.48%
Research & Development $250.0K $142.9K $240.0K
YoY Change 4.17% -7.99% -59.32%
% of Gross Profit 3.69% 447.3%
Depreciation & Amortization -$30.00K $60.00K $200.0K
YoY Change -115.0% 20.0% 11.11%
% of Gross Profit -0.44% 187.79%
Operating Expenses $870.0K $1.055M $780.0K
YoY Change 11.54% 96.53% -26.42%
Operating Profit $5.910M -$1.087M -$780.0K
YoY Change -857.69% 71.81% -38.58%
Interest Expense -$10.12M -$14.29M -$3.520M
YoY Change 187.5% -8038.89% -266.04%
% of Operating Profit -171.24%
Other Income/Expense, Net -$3.610M -$14.29M
YoY Change -7879.91%
Pretax Income -$7.820M -$15.37M -$4.310M
YoY Change 81.44% 3315.56% -601.16%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.820M -$15.37M -$4.300M
YoY Change 81.86% 3324.3% -600.0%
Net Earnings / Revenue -108.16% -29280.98%
Basic Earnings Per Share -$0.32
Diluted Earnings Per Share -$153.5K -$0.32 -$146.1K
COMMON SHARES
Basic Shares Outstanding 49.72M shares 47.39M shares 31.60M
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.830M $1.040M $0.00
YoY Change 10300.0% -100.0%
Cash & Equivalents $5.831M
Short-Term Investments
Other Short-Term Assets $460.0K $20.00K $10.00K
YoY Change 4500.0% -33.33% -50.0%
Inventory $1.406M $1.288M $1.231M
Prepaid Expenses $0.00 $22.72K $10.04K
Receivables $0.00 $40.00K $40.00K
Other Receivables $10.00K $10.00K $0.00
Total Short-Term Assets $7.744M $2.395M $1.281M
YoY Change 504.39% 97.83% 31.92%
LONG-TERM ASSETS
Property, Plant & Equipment $2.998M $26.31K $6.030K
YoY Change 49614.1% 305.53% -23.3%
Goodwill $0.00
YoY Change
Intangibles $1.545M $1.419M $1.353M
YoY Change 14.16% 3.87% -2.44%
Long-Term Investments $7.529M
YoY Change
Other Assets $1.545M $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $1.545M $1.445M $1.358M
YoY Change 13.8% 1.22% -4.22%
TOTAL ASSETS
Total Short-Term Assets $7.744M $2.395M $1.281M
Total Long-Term Assets $1.545M $1.445M $1.358M
Total Assets $12.29M $3.840M $2.645M
YoY Change 364.55% 45.54% 10.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $54.67K $509.9K $1.411M
YoY Change -96.12% -61.02% 32.47%
Accrued Expenses $575.7K $139.8K $503.0K
YoY Change 14.46% -74.78% -10.35%
Deferred Revenue
YoY Change
Short-Term Debt $170.0K $170.0K $2.070M
YoY Change -91.79% -90.17% 152.44%
Long-Term Debt Due $0.00 $1.080M $620.0K
YoY Change -100.0% 74.19% 44.19%
Total Short-Term Liabilities $984.3K $2.207M $4.603M
YoY Change -78.62% -48.27% 60.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.780M $18.64M $4.170M
YoY Change -9.35% 2453.42% 658.18%
Total Long-Term Liabilities $3.780M $18.64M $4.170M
YoY Change -9.35% 2453.42% 471.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $984.3K $2.207M $4.603M
Total Long-Term Liabilities $3.780M $18.64M $4.170M
Total Liabilities $4.764M $20.84M $8.776M
YoY Change -45.72% 317.13% 143.73%
SHAREHOLDERS EQUITY
Retained Earnings -$39.93M -$32.11M -$13.78M
YoY Change 189.84% 239.01% 95.65%
Common Stock $569.00 $344.00
YoY Change 65.41% 26.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.523M -$17.00M -$6.131M
YoY Change
Total Liabilities & Shareholders Equity $12.29M $3.840M $2.645M
YoY Change 364.55% 45.54% 10.73%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income -$7.820M -$15.37M -$4.300M
YoY Change 81.86% 3324.3% -600.0%
Depreciation, Depletion And Amortization -$30.00K $60.00K $200.0K
YoY Change -115.0% 20.0% 11.11%
Cash From Operating Activities $6.280M -$910.0K -$460.0K
YoY Change -1465.22% 237.04% -53.06%
INVESTING ACTIVITIES
Capital Expenditures -$680.0K -$60.00K -$160.0K
YoY Change 325.0% -72.88%
Acquisitions
YoY Change
Other Investing Activities -$2.970M -$10.00K $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.650M -$60.00K -$160.0K
YoY Change 2181.25% 433.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.170M 1.560M 620.0K
YoY Change 250.0% 457.14% -50.4%
NET CHANGE
Cash From Operating Activities 6.280M -910.0K -460.0K
Cash From Investing Activities -3.650M -60.00K -160.0K
Cash From Financing Activities 2.170M 1.560M 620.0K
Net Change In Cash 4.800M 590.0K 0.000
YoY Change 5800.0% -100.0%
FREE CASH FLOW
Cash From Operating Activities $6.280M -$910.0K -$460.0K
Capital Expenditures -$680.0K -$60.00K -$160.0K
Free Cash Flow $6.960M -$850.0K -$300.0K
YoY Change -2420.0% 214.81% -23.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Cash
Cash
1035767 USD
CY2012Q4 us-gaap Cash
Cash
188 USD
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1419088 USD
CY2012Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
36969 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3456642 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1732162 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4332 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
46045 USD
CY2013Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
40469 USD
CY2013Q3 us-gaap Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
7471 USD
CY2012Q4 us-gaap Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
3578 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
1288209 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
1230526 USD
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22723 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10044 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
2394639 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26311 USD
CY2013Q3 us-gaap Assets
Assets
3840038 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1410650 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139814 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
907993 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
503002 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
370240 USD
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11363 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4332 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-448925 USD
us-gaap Share Based Compensation
ShareBasedCompensation
946321 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1313201 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
57683 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
12679 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-297879 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
70211 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2013Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4232 USD
CY2013Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1445399 USD
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1363566 USD
CY2012Q4 us-gaap Assets
Assets
2644871 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1281305 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1353304 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6030 USD
CY2012Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
174925 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
509913 USD
CY2013Q3 xxii Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
15411 USD
CY2012Q4 xxii Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
3567 USD
CY2013Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1076564 USD
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4173140 USD
CY2013Q3 us-gaap Liabilities
Liabilities
20844241 USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
617000 USD
CY2013Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 USD
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1893804 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2206627 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4602948 USD
CY2013Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
18637614 USD
CY2013Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
174925 USD
CY2012Q4 us-gaap Liabilities
Liabilities
8776088 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32108253 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13776578 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7645017 USD
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-17004203 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3840038 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49050425 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49050425 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34286979 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34286979 shares
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
52500 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
15683 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
142912 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
155318 USD
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
63518 USD
CY2012Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
50458 USD
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
1139305 USD
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
648231 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1086805 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-632548 USD
CY2013Q3 xxii Derivative Gains Losses Net
DerivativeGainsLossesNet
-13727891 USD
CY2012Q3 xxii Derivative Gains Losses Net
DerivativeGainsLossesNet
535017 USD
CY2013Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
5672 USD
CY2012Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
55793 USD
CY2013Q3 us-gaap Interest Expense Other
InterestExpenseOther
552149 USD
CY2012Q3 us-gaap Interest Expense Other
InterestExpenseOther
295601 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14285712 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
17827 USD
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31048979 shares
us-gaap Sales Revenue Net
SalesRevenueNet
52500 USD
us-gaap Sales Revenue Net
SalesRevenueNet
15683 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
498746 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
484316 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
183623 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-15372517 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
us-gaap Depreciation And Amortization
DepreciationAndAmortization
173118 USD
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47389538 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
146374 USD
us-gaap Costs And Expenses
CostsAndExpenses
4153388 USD
us-gaap Costs And Expenses
CostsAndExpenses
2469749 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4100888 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2454066 USD
xxii Derivative Gains Losses Net
DerivativeGainsLossesNet
-13485564 USD
xxii Derivative Gains Losses Net
DerivativeGainsLossesNet
1167416 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
194074 USD
us-gaap Interest Expense Other
InterestExpenseOther
727396 USD
us-gaap Interest Expense Other
InterestExpenseOther
950647 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14230787 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22695 USD
us-gaap Profit Loss
ProfitLoss
-18331675 USD
us-gaap Profit Loss
ProfitLoss
-2431371 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1456 USD
us-gaap Net Income Loss
NetIncomeLoss
-18331675 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41203732 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29477387 shares
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4232 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
18954 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
134296 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1053987 USD
xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
526448 USD
xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
31350 USD
us-gaap Share Based Compensation
ShareBasedCompensation
776441 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
116940 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
476067 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-162579 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
473920 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
11844 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-17783 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-317810 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8842 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2422702 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1303250 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
22453 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92664 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
xxii Deferred Financing And Other Debt Related Costs
DeferredFinancingAndOtherDebtRelatedCosts
0 USD
xxii Deferred Financing And Other Debt Related Costs
DeferredFinancingAndOtherDebtRelatedCosts
10000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
56000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
543735 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
35000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
339250 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
786500 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2034664 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
xxii Proceeds Exercise Of Warrants
ProceedsExerciseOfWarrants
-2254999 USD
xxii Proceeds Exercise Of Warrants
ProceedsExerciseOfWarrants
0 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1660 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
3500 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
8478 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3893 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
57920 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3550945 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1056942 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1035579 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-246308 USD
CY2011Q4 us-gaap Cash
Cash
252249 USD
CY2012Q3 us-gaap Cash
Cash
5941 USD
us-gaap Interest Paid Net
InterestPaidNet
79015 USD
us-gaap Interest Paid Net
InterestPaidNet
13529 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
XXII
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49722180 shares
dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001347858
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
5197507 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2259522 USD
xxii Other Contributed Capital
OtherContributedCapital
1660 USD
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
0 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
245000 USD
xxii Increase Decrease In Capital
IncreaseDecreaseInCapital
204513 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
4290000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
2035000 USD
CY2013Q2 xxii Total Carrying Amount Of Convertible Notes
TotalCarryingAmountOfConvertibleNotes
223000 USD
CY2013Q1 xxii Total Carrying Amount Of Convertible Notes
TotalCarryingAmountOfConvertibleNotes
1409000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
215000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both;FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman,serif; MARGIN: 0in 0in 0pt; TEXT-INDENT: 36.3pt"> <strong><i><font style="FONT-SIZE: 10pt; COLOR: black"> Reclassifications</font></i></strong> <i><font style="COLOR: black; FONT-SIZE: 10pt">-</font></i> <font style="COLOR: black; FONT-SIZE: 10pt">Certain items in the 2012 financial statements have been reclassified to conform to the 2013 classification.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 xxii Contract Settlement Expected Costs
ContractSettlementExpectedCosts
3000000 USD
CY2013Q3 us-gaap Deferred Set Up Costs Noncurrent
DeferredSetUpCostsNoncurrent
40000 USD
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1710833 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both;FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman,serif; MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"> <strong><i><font style="FONT-SIZE: 10pt; COLOR: black">Use of Estimates</font></i></strong> <strong><font style="COLOR: black; FONT-SIZE: 10pt">-</font></strong> <font style="COLOR: black; FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2463316 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1044228 USD
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2226586 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
873282 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
245000 USD
CY2013Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2012Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5859 USD
CY2012 xxii Volume Of Commodity Sold
VolumeOfCommoditySold
12000000 Number
CY2011 xxii Volume Of Commodity Sold
VolumeOfCommoditySold
12000000 Number
xxii Volume Of Commodity Sold
VolumeOfCommoditySold
0 Number
xxii Volume Of Commodity Sold
VolumeOfCommoditySold
0 Number
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
245000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
245000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
245000 USD
CY2012Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1710833 shares
CY2012Q2 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
1026500 USD
CY2012Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
786500 USD
CY2012Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
150000 USD
CY2012Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.04 pure
CY2012Q2 xxii Non Cash Equity Method Investments
NonCashEquityMethodInvestments
90000 USD
CY2012Q2 xxii Warrants Exercise Price
WarrantsExercisePrice
1.00
CY2012Q2 xxii Issuance Of Warrant Value
IssuanceOfWarrantValue
1841000 USD
CY2012Q2 xxii Non Cash Consideration Expense
NonCashConsiderationExpense
814500 USD
CY2012Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3238000 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1619000 shares
CY2012Q4 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
809500 USD
CY2012Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
681000 USD
CY2012Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
98500 USD
CY2012Q4 xxii Forgiveness Of Directors Fees
ForgivenessOfDirectorsFees
30000 USD
CY2012Q4 xxii Warrants Exercise Price
WarrantsExercisePrice
1.00
CY2012Q4 xxii Issuance Of Warrant Value
IssuanceOfWarrantValue
353747 USD
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075 pure
CY2013Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0400 pure
xxii Loan Repayment Terms Minimum
LoanRepaymentTermsMinimum
P30D
CY2012 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075 pure
CY2012Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0400 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
680000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
680000 shares
CY2011Q4 us-gaap Share Price
SharePrice
0.90
CY2013Q4 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
155153 USD
CY2012Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
308011 USD
CY2013Q4 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
181233 USD
CY2012Q4 xxii Convertible Notes Face Amount
ConvertibleNotesFaceAmount
120750 USD
CY2012Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
55000 USD
CY2012 xxii Conversion Of Convertible Notes Shares Of Common Stock Per Convertible Note
ConversionOfConvertibleNotesSharesOfCommonStockPerConvertibleNote
161494 shares
CY2012 xxii Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
193793 shares
CY2012Q4 xxii Unamortized Discount On Convertible Notes
UnamortizedDiscountOnConvertibleNotes
66000 USD
CY2012 xxii Warrant Liabilities Fair Value
WarrantLiabilitiesFairValue
152000 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
31000 USD
CY2011 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
22500 USD
CY2013Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
396750 USD
CY2013Q1 xxii Warrant Liabilities Fair Value
WarrantLiabilitiesFairValue
1445091 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
17386 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2013Q3 xxii Convertible Debt Fair Value
ConvertibleDebtFairValue
0 USD
CY2012Q4 xxii Convertible Debt Fair Value
ConvertibleDebtFairValue
2028100 USD
CY2013Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1893804 USD
CY2013Q3 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.03 pure
CY2013Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
4165 USD
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
27723 USD
xxii Agreement Expiration Period
AgreementExpirationPeriod
2022
xxii Milestone Payment
MilestonePayment
150000 USD
xxii Patent Initiative Expenses
PatentInitiativeExpenses
83800 USD
xxii Patent Initiative Expenses
PatentInitiativeExpenses
55853 USD
CY2013Q3 xxii Annual License Fee
AnnualLicenseFee
75000 USD
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0189 pure
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0171 pure
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
465000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.69
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.80
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.73
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.73
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y9M18D
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
383100 USD
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
383100 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
15000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
45000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
10000 USD
xxii Working Capital
WorkingCapital
188012 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
134000 USD
CY2013Q3 xxii Unrecognized Compensation Expense To Be Recognized In Next Twelve Months
UnrecognizedCompensationExpenseToBeRecognizedInNextTwelveMonths
34000 USD
CY2013Q3 xxii Unrecognized Compensation Expense To Be Recognized In Year Two
UnrecognizedCompensationExpenseToBeRecognizedInYearTwo
49000 USD
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47389538 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31048979 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2013Q3 xxii Unrecognized Compensation Expense To Be Recognized In Year Three
UnrecognizedCompensationExpenseToBeRecognizedInYearThree
51000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
186959 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
242020 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41203732 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29477387 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20796308 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18045887 shares
CY2013Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
290000 USD
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20550 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
60852 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
20550 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
60852 USD
CY2013Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
222600 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
210000 USD
CY2012Q4 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2013Q3 xxii Conversion Of Convertible Notes Shares Of Common Stock Per Convertible Note
ConversionOfConvertibleNotesSharesOfCommonStockPerConvertibleNote
371000 shares
CY2013Q3 xxii Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
371000 shares
CY2013Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.00
CY2013Q3 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2013Q3 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
1000000 USD
CY2013Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
200000 USD
CY2013Q3 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
800000 USD
xxii Exercise Of Warrants Upon Conversion Of Equity On Cashless Basis
ExerciseOfWarrantsUponConversionOfEquityOnCashlessBasis
1160080 shares
xxii Warrant Liabilities Fair Value
WarrantLiabilitiesFairValue
1445091 USD
xxii Exercise Of Warrants For Cash
ExerciseOfWarrantsForCash
275000 shares
xxii Warrant Issued
WarrantIssued
1101034 shares
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
17386 USD
CY2011Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
550000 USD
CY2013Q3 xxii Common Stock Issued Price Per Share
CommonStockIssuedPricePerShare
1.31
CY2012 xxii Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
1183543 USD
xxii Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
9154830 USD
CY2011Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8668701 shares
CY2012Q4 xxii Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
3523033 shares
CY2012 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
780930 shares
CY2012 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2013Q3 xxii Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
11570274 shares
xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
1225895 shares
xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
-6152525 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
19616308 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12972664 shares
xxii Fees And Expense Reimbursements Paid
FeesAndExpenseReimbursementsPaid
1800000 USD
CY2013Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
24233 USD
CY2012Q4 xxii Number Of Warrants Issued During Period
NumberOfWarrantsIssuedDuringPeriod
1619000 shares
CY2012Q4 xxii Estimated Fairvalue Of Warrants
EstimatedFairvalueOfWarrants
353747 USD
xxii Lease Term
LeaseTerm
P3Y
CY2013Q3 xxii Maximum Exposure Amount For Contingent Liability
MaximumExposureAmountForContingentLiability
1183333 USD
xxii Warrants Issued During Period Value
WarrantsIssuedDuringPeriodValue
168402 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.00
CY2013Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
93361 USD
xxii Adjustments To Additional Paid In Capital Accrued Dividend Payable
AdjustmentsToAdditionalPaidInCapitalAccruedDividendPayable
93361 USD
xxii Issuance Of Common Stock In Exchange For Account Payable
IssuanceOfCommonStockInExchangeForAccountPayable
0 USD
xxii Issuance Of Common Stock In Exchange For Account Payable
IssuanceOfCommonStockInExchangeForAccountPayable
-359754 USD
xxii Issuance Of Common Stock In Exchange For Deferred Private Placement Payable
IssuanceOfCommonStockInExchangeForDeferredPrivatePlacementPayable
0 USD
xxii Issuance Of Common Stock In Exchange For Deferred Private Placement Payable
IssuanceOfCommonStockInExchangeForDeferredPrivatePlacementPayable
-36875 USD
xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
769377 USD
xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
0 USD
xxii Supplemental Accounts Payable
SupplementalAccountsPayable
769377 USD
xxii Supplemental Accounts Payable
SupplementalAccountsPayable
396629 USD
xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
26422 USD
xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
0 USD
xxii Common Stock To Be Issued For Services
CommonStockToBeIssuedForServices
0 USD
xxii Common Stock To Be Issued For Services
CommonStockToBeIssuedForServices
171246 USD
xxii Deferred Private Placement Costs Charged To Contributed Capital
DeferredPrivatePlacementCostsChargedToContributedCapital
0 USD
xxii Deferred Private Placement Costs Charged To Contributed Capital
DeferredPrivatePlacementCostsChargedToContributedCapital
4526 USD
xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
1650305 USD
xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
120750 USD
xxii Increase Decrease In Original Issue Disount On Convertible Debt
IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt
0 USD
xxii Increase Decrease In Original Issue Disount On Convertible Debt
IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt
12600 USD
xxii Increase Decrease In Beneficial Conversion Feature
IncreaseDecreaseInBeneficialConversionFeature
0 USD
xxii Increase Decrease In Beneficial Conversion Feature
IncreaseDecreaseInBeneficialConversionFeature
63600 USD
xxii Issuance Of Common Stock Value In Payments Of Financing Cost
IssuanceOfCommonStockValueInPaymentsOfFinancingCost
416666 shares
xxii Issuance Of Common Stock Value In Payments Of Financing Cost
IssuanceOfCommonStockValueInPaymentsOfFinancingCost
0 shares
xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
93361 USD
xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
0 USD
xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
57500 USD
xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
0 USD
xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
5675634 USD
xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
152100 USD
xxii Increase In Warrant Liability And Reduction In Capital Due Changes In Exercise Price Of Warrant
IncreaseInWarrantLiabilityAndReductionInCapitalDueChangesInExercisePriceOfWarrant
626328 USD
xxii Increase In Warrant Liability And Reduction In Capital Due Changes In Exercise Price Of Warrant
IncreaseInWarrantLiabilityAndReductionInCapitalDueChangesInExercisePriceOfWarrant
0 USD
xxii Issuance Of Warrants As Derivative Liability Instruments
IssuanceOfWarrantsAsDerivativeLiabilityInstruments
0 USD
xxii Issuance Of Warrants As Derivative Liability Instruments
IssuanceOfWarrantsAsDerivativeLiabilityInstruments
92750 USD
xxii Issuance Of Derivative Liability
IssuanceOfDerivativeLiability
290000 USD
xxii Issuance Of Derivative Liability
IssuanceOfDerivativeLiability
0 USD
xxii Reclassification Of Derivative Liability To Equity
ReclassificationOfDerivativeLiabilityToEquity
5849500 USD
xxii Reclassification Of Derivative Liability To Equity
ReclassificationOfDerivativeLiabilityToEquity
0 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
166521 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
124080 USD
xxii Deferred Private Placement Cost Additions Included In Accounts Payable
DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable
0 USD
xxii Deferred Private Placement Cost Additions Included In Accounts Payable
DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable
5000 USD

Files In Submission

Name View Source Status
0001144204-13-060642-index-headers.html Edgar Link pending
0001144204-13-060642-index.html Edgar Link pending
0001144204-13-060642.txt Edgar Link pending
0001144204-13-060642-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v359127_10q.htm Edgar Link pending
v359127_ex31-1.htm Edgar Link pending
v359127_ex31-2.htm Edgar Link pending
v359127_ex32-1.htm Edgar Link pending
xxii-20130930.xml Edgar Link completed
xxii-20130930.xsd Edgar Link pending
xxii-20130930_cal.xml Edgar Link unprocessable
xxii-20130930_def.xml Edgar Link unprocessable
xxii-20130930_lab.xml Edgar Link unprocessable
xxii-20130930_pre.xml Edgar Link unprocessable